David Springer, GID BIO - Cellular Therapy Development | LSI Europe '25

GID BIO is a biotechnology company dedicated to advancing innovative cellular therapies aimed at revolutionizing patient care and improving quality of life. Leveraging cutting-edge technology and research, they focus on delivering transformative solutions for complex medical conditions.